IP Library Granted Patent US 7,186,560
Granted Patent B2
US 7,186,560 · App. 10/109,812 · Granted Mar 6, 2007

High level expression of immunogenic proteins in the plastids of higher plants

Assignee: Rutgers, The State University of New Jersey
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,560
App. No.
10/109,812
Granted
Mar 6, 2007
Kind
B2
Abstract

A site specific recombination system and methods of use thereof are disclosed for manipulating the genome of higher plants. Compositions and methods for expressing immunogenic proteins using the site specific reombination system are also provided.

Claims (13)

1. A nucleic acid construct for expression of at least one immunogenic protein in plant plastids, comprising:

a) a nucleic acid sequence encoding at least one immunogenic protein, wherein said sequence comprises SEQ ID NO: 33, encoding LTK63, and

b) a nucleic acid sequence encoding a selectable marker;

said sequence of a) and said selectable marker encoding nucleic acid being operably linked to 5′ and 3′ regulatory sequences which function in the plastids of plants, wherein said selectable marker gene allows for the selection of cells comprising plastids transformed with said nucleic acid construct.

2. The nucleic acid construct of claim 1 , wherein the nucleic acid sequence of a) also comprises SEQ ID NO:31, encoding TetC.

3. A vector comprising the nucleic acid construct of claim 1 .

4. A plant cell comprising the vector of claim 3 .

5. The nucleic acid construct of claim 1 , wherein expression of said selectable marker encoding nucleic acid confers resistance to a selectable agent selected from the group consisting of kanamycin, gentamycin, spectinomycin, streptomycin and hygromycin, phosphinotricin, basta, glyphosate and bromoxynil.

6. A plant comprising the plant cell of claim 4 .

7. The nucleic acid construct of claim 1 , wherein said at least one immunogenic protein is selected from the group consisting of a vaccine antigen and a mucosal adjuvant.

8. The nucleic acid construct of claim 1 , wherein said selectable marker gene is flanked by site-specific recombinase excision sites.

9. The nucleic acid construct of claim 8 , wherein said excision sites are selected from the group consisting of LOX sequences and frt sequences.

10. The nucleic acid construct of claim 1 , wherein said sequence encoding at least one immunogenic protein is SEQ ID NO: 33.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2002
From: MALIGA, PAL; DOUGAN, GORDON; TREGONING, JOHN; NIXON, PETER
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 013103/0856 →
Continuity (6)
Continuation In Part 1008863400
Provisional Application 6027959100 · Mar 29, 2001
Provisional Application 6033569900 · Oct 25, 2001
Provisional Application 6021113900 · Jun 13, 2000
Provisional Application 6015500700 · Sep 21, 1999
Related Publication 20030088081A1 · May 8, 2003